CRT 2024

Panel Discussion: What Have We Learned from the Past 30 Years on the Pathophysiology of Cardiogenic Shock

Panel Moderator(s)

• 

  Allison Dupont, MD, FACC, FSCAI

  Interventional Cardiologist
  Northside Cardiovascular Institute
  Gainesville, Georgia, United States

  No relationships to disclose
• 

  Mitchell Krucoff, MD, FACC

  Professor Medicine/Cardiology
  Duke University Medical Center/Duke Clinical Research Institute
  Durham, North Carolina, United States

  Disclosure information not submitted.

Panel Discussant(s)

• 

  James A. Goldstein, MD, FSCAI

  Director, Research and Education
  Beaumont Health System
  Royal Oak, Michigan, United States

  Disclosure information not submitted.
• 

  Daniel Burkhoff, MD, PhD

  Director: Heart Failure, Hemodynamics and MCS Research
  Cardiovascular Research Foundation
  New York, New York, United States

  Disclosure information not submitted.
• 

  Tariq Enezate, MD

  Interventional Cardiology Faculty
  OSF-Urbana
  Urbana, Illinois, United States

  No relationships to disclose
• 

  Maya Guglin, MD

  Director of Heart Failure/Transplant/MCS
  Indiana University
  Indianapolis, Indiana, United States

  Disclosure information not submitted.
• 

  Amir Kaki, MD, FACC, FSCAI

  Director Mechanical Circulatory Support Director High-Risk Complex Coronary Interventions
  Ascension St John Hospital
  Southfield, Michigan, United States

  Disclosure information not submitted.
• 

  Mohit Pahuja, MD

  Assistant Professor of Medicine, Division of Interventional and advanced heart failure cardiology
  University of Oklahoma Medical Center
  OKC, Oklahoma, United States

  Disclosure(s): No financial relationships to disclose
• 

  Saraschandra Vallabhajosyula, MD MSc

  Assistant Professor of Medicine
  Warren Alpert Medical School of Brown University
  Providence, Rhode Island, United States

  No relationships to disclose